Changes in early visual perception in patients with minimal hepatic encephalopathy

Changes in early visual perception in patients with minimal hepatic encephalopathy

Introduction and Objective: Minimal Hepatic Encephalopathy (MHE) is characterized by very subtle cognitive changes that are diagnosed with the Psychometric hepatic encephalopathy score (PHES) and critical flickering frequency (CFF). Patients with MHE are slower in attention tests evaluated with visu...

Full description

Bibliographic Details
Main Authors:	D Montemira-Orozco, CI Hinojosa-Segura, A Burak-Leipuner, J Zavala-Ramírez, IG Cruz-Reyes, M Escobedo-Silva, F Higuera-de la Tijera, JL Pérez-Hernández, D Santana-Vargas
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	Annals of Hepatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268122001284

Similar Items

Short-term response of p300 evoked potential in patients with minimal hepatic encephalopathy treated with l-ornithine, l-aspartate
by: CI Hinojosa-Segura, et al.
Published: (2022-12-01)

Sarcopenia as a predictor of risk of minimal hepatic encephalopathy in patients with liver cirrhosis
by: O Morales Gutiérrez, et al.
Published: (2022-12-01)

P 56- SHORT-TERM RESPONSE OF P300 EVOKED POTENTIAL IN PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY TREATED WITH L-ORNITHINE, L-ASPARTATE
by: José Luis Pérez-Hernández, et al.
Published: (2023-03-01)

The Stroop test validation in the detection of minimal hepatic encephalopathy in Mexican patients with cirrhosis, preliminary results
by: PF Domínguez Cardoso, et al.
Published: (2022-12-01)

P- 91 CHANGES IN EARLY VISUAL PERCEPTION IN PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY
by: José Luis Pérez Hernández, et al.
Published: (2023-03-01)

Short-term efficacy and safety of l-ornithine l-aspartate therapy in patients with cirrhosis and minimal hepatic encephalopathy: a real-life cohort study
by: AB Moreno-Cobos, et al.
Published: (2022-12-01)

P-31 SHORT-TERM EFFICACY AND SAFETY OF LOLA THERAPY IN PATIENTS WITH CIRRHOSIS AND MINIMAL HEPATIC ENCEPHALOPATHY: A REAL-LIFE COHORT STUDY
by: Fátima Higuera-De La Tijera, et al.
Published: (2023-03-01)

Validation of S-ANT for the diagnosis of minimal hepatic encephalopathy
by: Ángel D. Santana-Vargas, et al.
Published: (2024-02-01)

Efficacy and safety of intravenous L-ornithine L-aspartate in patients with grade III and IV hepatic encephalopathy
by: Gabriela Rangel-Zavala, et al.
Published: (2024-02-01)

P-41 SARCOPENIA AS A PREDICTOR OF RISK OF MINIMAL HEPATIC ENCEPHALOPATHY IN PATIENTS WITH LIVER CIRRHOSIS
by: Oscar Morales Gutiérrez, et al.
Published: (2023-03-01)

Minimal Hepatic Encephalopathy
by: Laura M Stinton, et al.
Published: (2013-01-01)

Pathophysiology of hepatic encephalopathy and future treatment options
by: J.A. González-Regueiro, et al.
Published: (2019-04-01)

Prevalence of high-risk non-alcoholic steatohepatitis according to the fast® index in a group of diabetic patients
by: A Burak-Leipuner, et al.
Published: (2022-12-01)

Prediction of minimal hepatic encephalopathy
by: Sangheun Lee, et al.
Published: (2012-01-01)

Prevalence of fibrosis and steatosis determined by transition elastography and controlled attenuation parameter (fibroscanâ) in diabetic patients
by: A Burak-Leipuner, et al.
Published: (2022-12-01)

Minimal hepatic encephalopathy – diagnosis and treatment
by: Wojciech Pisarek
Published: (2021-12-01)

25-hydroxyvitamin D deficiency as a factor associated with the development of Hepatic Encephalopathy in the Mexican population.
by: Paloma Diego-Salazar, et al.
Published: (2024-02-01)

Usefulness of the Stroop Test in Diagnosing Minimal Hepatic Encephalopathy and Predicting Overt Hepatic Encephalopathy
by: Tatsunori Hanai, et al.
Published: (2021-09-01)

Chronotypology and melatonin alterations in minimal hepatic encephalopathy
by: Polychronopoulos Panagiotis, et al.
Published: (2009-05-01)

Predictors of minimal hepatic encephalopathy in patients with cirrhosis
by: Sharma Praveen, et al.
Published: (2010-01-01)

Prevalence of minimal hepatic encephalopathy in cirrhotic patients
by: Héctor Jesús Maldonado-Garza, et al.
Published: (2011-01-01)

Minimal hepatic encephalopathy. Should we treat it?
by: Liz Toapanta-Yanchapaxi, et al.
Published: (2013-05-01)

The role of Helicobacter pylori in minimal hepatic encephalopathy
by: Seham S El-seid, et al.
Published: (2015-01-01)

Predicting overt hepatic encephalopathy after TIPS: Value of three minimal hepatic encephalopathy tests
by: Alena F. Ehrenbauer, et al.
Published: (2023-09-01)

IGFBP-1 TO 7 AS BIOMARKERS IN STAGES OF LIVER FIBROSIS DURING VIRAL HEPATITIS C
by: M. Martínez-Castillo, et al.
Published: (2022-01-01)

Minimal hepatic encephalopathy - from cirrhosis to neurological disorders
by: Jakub Jarmołowicz, et al.
Published: (2024-12-01)

The Prevalence of Minimal Hepatic Encephalopathy in an Outpatient Hepatology Clinic
by: Deniz Eyice, et al.
Published: (2023-05-01)

Minimal hepatic encephalopathy is associated to alterations in eye movements
by: Franc Casanova-Ferrer, et al.
Published: (2022-10-01)

Detection of Minimal Hepatic Encephalopathy in Iranian Patients with Cirrhosis
by: Mahsa Khodadoostan, et al.
Published: (2018-10-01)

Multistrain probiotic and lactulose in the treatment of minimal hepatic encephalopathy
by: Ahmad Shavakhi, et al.
Published: (2014-01-01)

Minimal hepatic encephalopathy: current clinical and pathogenetic aspects
by: I V Damulin
Published: (2018-02-01)

Minimal Hepatic Encephalopathy: The Reality Beyond Our Eyes
by: Mara Barbosa, et al.
Published: (2015-07-01)

Thalamic Structural Connectivity Abnormalities in Minimal Hepatic Encephalopathy
by: Hua-Jun Chen, et al.
Published: (2021-02-01)

Role of minimal hepatic encephalopathy in road traffic accidents
by: Mohammad Mohai El-Din Awad, et al.
Published: (2019-01-01)

Minimal Hepatic Encephalopathy in Cirrhosis- How Long to Treat?
by: Omesh Goyal, et al.
Published: (2017-01-01)

Current vision on diagnosis and comprehensive care in hepatic encephalopathy
by: F. Higuera-de-la-Tijera, et al.
Published: (2023-04-01)

Epidemiologic profile of non-alcoholic fatty liver disease in apparently healthy blood bank donors
by: JE Lira-Vera, et al.
Published: (2022-12-01)

Prevalence of non-alcoholic fatty liver disease in apparently healthy blood bank donors: metabolic, alcohol, and combined damage
by: JE Lira-Vera, et al.
Published: (2022-12-01)

O-33 PREVALENCE OF HIGH-RISK NON-ALCOHOLIC STEATOHEPATITIS ACCORDING TO THE FAST® INDEX IN A GROUP OF DIABETIC PATIENTS
by: Andrés Burak-Leipuner, et al.
Published: (2023-03-01)

The usefulness of 3 different points of the liver to evaluate fibrosis by transitional elastography
by: E Morales-Mairena, et al.
Published: (2022-12-01)